<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.115302</article-id><article-id pub-id-type="publisher-id">ACM-42297</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210500000_75181484.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  JNK在脑缺血再灌注损伤细胞凋亡中的作用
  The Role of JNK in Apoptosis after Cerebral Ischemia-Reperfusion Injury
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>海鹏</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>于</surname><given-names>群</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>明山</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>潍坊医学院麻醉学院，山东 潍坊</addr-line></aff><aff id="aff2"><addr-line>青岛大学青岛医学院，山东 青岛 </addr-line></aff><aff id="aff4"><addr-line>青岛大学附属青岛市市立医院麻醉科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>05</month><year>2021</year></pub-date><volume>11</volume><issue>05</issue><fpage>21111</fpage><lpage>2119</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  缺血性脑卒中发病率逐年增高，严重威胁人们的健康与生活质量，脑缺血/再灌注损伤(CIRI)是其发病及治疗过程中常见的不良后果之一。c-jun氨基末端激酶(JNK)信号转导通路在CIRI中起着重要的调控作用，参与介导了神经元凋亡等病理生理过程，是防治CIRI的重要靶点。许多研究提示，JNK抑制剂可以减少CIRI引起的细胞凋亡，发挥神经保护作用，可为临床上缺血性脑卒中的治疗提供新的思路，同时对寻找新的药物靶点和筛选新药都具有重要的理论意义。
   The incidence rate of ischemic stroke is increasing year by year, which seriously threatens people’s health and quality of life. Cerebral ischemia/reperfusion injury (CIRI) is one of the common adverse consequences in the course of its onset and treatment. C-Jun N-terminal kinase (JNK) signal transduction pathway plays an important role in the regulation of CIRI. It participates in the pathophysiological processes such as neuronal apoptosis, and is an important target for the prevention and treatment of CIRI. Many studies suggest that JNK inhibitors can reduce the apoptosis induced by CIRI and play a neuroprotective role, which can provide a new idea for the treatment of ischemic stroke in clinic. At the same time, it has important theoretical significance for finding new drug targets and screening new drugs.
 
</p></abstract><kwd-group><kwd>脑缺血/再灌注损伤，JNK信号通路，细胞凋亡，抑制剂, Cerebral Ischemia/Reperfusion Injury</kwd><kwd> JNK Signaling Pathway</kwd><kwd> Apoptosis</kwd><kwd> Inhibitor</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>缺血性脑卒中发病率逐年增高，严重威胁人们的健康与生活质量，脑缺血/再灌注损伤(CIRI)是其发病及治疗过程中常见的不良后果之一。c-jun氨基末端激酶(JNK)信号转导通路在CIRI中起着重要的调控作用，参与介导了神经元凋亡等病理生理过程，是防治CIRI的重要靶点。许多研究提示，JNK抑制剂可以减少CIRI引起的细胞凋亡，发挥神经保护作用，可为临床上缺血性脑卒中的治疗提供新的思路，同时对寻找新的药物靶点和筛选新药都具有重要的理论意义。</p></sec><sec id="s2"><title>关键词</title><p>脑缺血/再灌注损伤，JNK信号通路，细胞凋亡，抑制剂</p></sec><sec id="s3"><title>The Role of JNK in Apoptosis after Cerebral Ischemia-Reperfusion Injury<sup> </sup></title><p>Haipeng Wang<sup>1</sup>, Qun Yu<sup>2</sup>, Mingshan Wang<sup>3*</sup></p><p><sup>1</sup>Qingdao Medical College, Qingdao University, Qingdao Shandong</p><p><sup>2</sup>College of Anesthesiology, Weifang Medical University, Weifang Shandong</p><p><sup>3</sup>Department of Anesthesiology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/11-1572200x5_hanspub.png" /></p><p>Received: Apr. 11<sup>th</sup>, 2021; accepted: Apr. 25<sup>th</sup>, 2021; published: May 17<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/11-1572200x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>The incidence rate of ischemic stroke is increasing year by year, which seriously threatens people’s health and quality of life. Cerebral ischemia/reperfusion injury (CIRI) is one of the common adverse consequences in the course of its onset and treatment. C-Jun N-terminal kinase (JNK) signal transduction pathway plays an important role in the regulation of CIRI. It participates in the pathophysiological processes such as neuronal apoptosis, and is an important target for the prevention and treatment of CIRI. Many studies suggest that JNK inhibitors can reduce the apoptosis induced by CIRI and play a neuroprotective role, which can provide a new idea for the treatment of ischemic stroke in clinic. At the same time, it has important theoretical significance for finding new drug targets and screening new drugs.</p><p>Keywords:Cerebral Ischemia/Reperfusion Injury, JNK Signaling Pathway, Apoptosis, Inhibitor</p><disp-formula id="hanspub.42297-formula3"><graphic xlink:href="//html.hanspub.org/file/11-1572200x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/11-1572200x8_hanspub.png" /> <img src="//html.hanspub.org/file/11-1572200x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>脑卒中位于冠心病和癌症之后，是西方国家人口的第三大死因 [<xref ref-type="bibr" rid="hanspub.42297-ref1">1</xref>]。在中国脑卒中已超过心脏病成为导致死亡和成人残疾的首要病因 [<xref ref-type="bibr" rid="hanspub.42297-ref2">2</xref>]，其中缺血性脑卒中是最常见的类型，占比69.6%~70.8% [<xref ref-type="bibr" rid="hanspub.42297-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.42297-ref4">4</xref>]。缺血性脑卒中的治疗原则是尽快恢复缺血区的血液灌注，以减轻脑组织损伤，但是在抢救和治疗过程中，发现快速恢复血液供应反而使组织损伤及功能障碍进一步加重，即CIRI [<xref ref-type="bibr" rid="hanspub.42297-ref5">5</xref>]。CIRI的发生和发展是一个复杂的病理生理过程，目前认为主要与能量代谢障碍、氧化应激、钙超载、炎性因子及一氧化氮合成释放过多、兴奋性氨基酸的神经毒性等密切相关 [<xref ref-type="bibr" rid="hanspub.42297-ref6">6</xref>]。众多研究表明，JNK信号通路及其抑制剂在CIRI诱导的细胞凋亡中起重要的调控作用。现就CIRI中JNK介导神经细胞凋亡的机制及JNK抑制剂的应用展开综述。</p></sec><sec id="s6"><title>2. JNK信号通路概述</title><p>促分裂原活化蛋白激酶(MAPKs)是在哺乳动物细胞内广泛存在且进化保守的丝/苏氨酸(Ser/Thr)蛋白激酶类信号分子家族，主要成员有四种：细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)、p38丝裂原活化蛋白激酶(p38 MAPK)以及细胞外信号调节蛋白激酶5(ERK5)。这些激酶的信号通路高度保守，均通过三级酶促磷酸化级联反应将细胞外信号传递到细胞质与细胞核，即MAPK激酶的激酶(MAPKKK/MEKK)-MAPK激酶(MAPKK/MEK)-MAPK。不同激酶的信号通路相对独立，介导的效应因细胞类型、刺激种类和方式的不同而有很大的差异，ERK通路优先传递有丝分裂原和生长因子产生的刺激信号，p38和JNK通路对紫外线照射、渗透压改变、热休克及炎性细胞因子等物理和化学环境应激具有更强的选择性，ERK5则可被高渗压、低氧、氧化剂和流体切应力等激活。</p><p>JNK于上世纪九十年代初在紫外线照射细胞的研究中被发现，哺乳动物中有3个基因型，即JNK1，JNK2和JNK3，经过选择性剪切可以编码10种异构体，包括分子量46 kDa的JNK1α1、JNK1β1、JNK2α1、JNK2β1，55 kDa的JNK1α2、JNK1β2、JNK2α2、JNK2β2，48 kDa的JNK3α1以及57 kDa的JNK3α2，亚型间的同源性可达85%以上，所有亚型的亚结构域Ⅷ中都含有保守的Thr-Pro-Tyr序列，其上的苏氨酸(Thr)/酪氨酸(Tyr)的双重磷酸化介导JNK的激活。JNK1和 JNK2在组织中广泛表达，而JNK3有一个与甲硫氨酸残基相融合的扩展N端，仅选择性表达于脑、心脏和睾丸等部位。有研究发现 [<xref ref-type="bibr" rid="hanspub.42297-ref7">7</xref>]，JNK1和JNK2在神经发育中起着重要作用，JNK3则与应激诱导的神经细胞凋亡密切相关。</p><p>JNK信号通路可对多种胞外刺激作出应答，如膜受体相关的细胞因子(TNFα、IL-1)和生长因子(EGF、TGF-β、PDGF)以及非受体途径的热休克、电离辐射、紫外线照射、渗透压、缺血再灌注和氧化损伤等环境应激因素 [<xref ref-type="bibr" rid="hanspub.42297-ref8">8</xref>]。胞外刺激进一步激活了JNK的上游级联激酶，即MAPKKK-MAPKK，MAPKKK类激酶主要包括MEKK1-4、DLK、Tpl-2、ASK1-2、MLK1-3、TAK1和TAO1-2等，MLK2/3还可受到Rho家族小GTP酶Rac1、Cdc42的调控，MAPKKK因其亚型的多样性而有助于JNK通路对胞外刺激信号的特异性应答；MAPKK类激酶包括MEK4和MEK7，是JNK的特异性激酶，通过对Thr-Pro-Tyr序列中Thr183和Tyr185位点双磷酸化而激活JNK，MEK4优先磷酸化Tyr185，而MEK7优先磷酸Thr183 [<xref ref-type="bibr" rid="hanspub.42297-ref9">9</xref>]。双重特异性磷酸酶(DUSPs)作为受JNK调控的下游靶蛋白，可通过去磷酸化负反馈抑制使JNK及时失活 [<xref ref-type="bibr" rid="hanspub.42297-ref10">10</xref>]。在静止的细胞中，JNK主要定位于细胞浆，激活后部分转入细胞核内，使转录因子c-Jun氨基末端63和73位丝氨酸残基发生磷酸化激活，增强其转录活性，促进转录激活蛋白-1 (AP-1)复合体的形成，后者结合到许多基因启动子区的AP-1位点，调控基因的表达与蛋白质合成。JNK的下游底物除了细胞核内众多的转录因子(c-jun、JunB、JunD、ATF2、P53、Elk-1 、STAT1、STAT3、Smad4、c -myc、NFATc1-3和HSF-1等)，还包含一些细胞质成分，如细胞骨架蛋白(DCX、Tau、WDR62)、凋亡相关蛋白Bcl-2家族成员(Bcl-2、Bcl-xl、Bim、Bad)等。此外JNK调控路径上还包含一些重要的支架蛋白，如JIP、JLP、β-arrestin、CrkII、JAMP、POSH等，能与特定的MEKK、MEK、JNK结合形成功能性复合体，调节它们的细胞内定位和活性，对信号传递的特异性及效率起到重要的调节作用 [<xref ref-type="bibr" rid="hanspub.42297-ref11">11</xref>]。JNK磷酸化下游底物，涉及复杂的蛋白质相互作用，参与细胞增殖、分化、形态维持、骨架构建、凋亡、DNA损伤修复等多种生物学反应 [<xref ref-type="bibr" rid="hanspub.42297-ref12">12</xref>]，JNK信号通路功能失调则与神经退行性疾病、脑卒中、糖尿病、慢性炎症、癌症等多种疾病的发生密切相关。</p></sec><sec id="s7"><title>3. JNK信号通路与脑缺血再灌注损伤细胞凋亡</title><p>细胞凋亡是一种不同于细胞坏死的，由基因精确调控的程序性死亡方式，是一种重要的机体自稳态调控机制。JNK作为MAPK信号级联途径中的重要一环，在CIRI诱导的神经细胞凋亡过程中发挥着重要的调控作用 [<xref ref-type="bibr" rid="hanspub.42297-ref13">13</xref>]。ZHU等 [<xref ref-type="bibr" rid="hanspub.42297-ref14">14</xref>] 发现短暂性全脑缺血再灌注引起大鼠海马 CA1区GluK6的泛素化水平持续升高，使其与MLK3的结合增加，下游JNK3被过度激活，可能是缺血再灌后神经元凋亡的原因。ZHEN等 [<xref ref-type="bibr" rid="hanspub.42297-ref15">15</xref>] 通过缺血2 h、再灌注22 h构建了小鼠局灶性CIRI模型，发现假手术组p-JNK表达很低，CIRI组大脑皮质和海马区p-JNK表达急剧上升，抑制JNK的激活可改善CIRI大鼠的神经行为功能，缩减脑组织的梗死面积。这些结果表明，JNK信号通路的激活参与了CIRI，但具体机制尚未阐述透彻。目前的研究表明CIRI通过JNK信号通路诱导神经元凋亡主要涉及三条路径：线粒体途径、死亡受体途径、内质网途径。</p><sec id="s7_1"><title>3.1. 线粒体途径</title><p>JNK可通过非转录依赖的方式直接调控细胞质内靶蛋白的活性而介导细胞凋亡。一部分活化的JNK 留在细胞质中，通过磷酸化Bcl-2家族成员而介导线粒体途径细胞凋亡的发生，此过程并不促进基因的转录表达。Bcl-2家族成员根据其结构和功能的差异性可分为3类，即Bcl2、Bcl-xl、Bcl-w等抗凋亡蛋白，Bax、Bak、Bok等促凋亡蛋白以及Bid、Bim、Bad、Puma等BH3-only蛋白。其中Bax是线粒体通路的主要效应者。活性JNK能磷酸化直接激活Bax，也能磷酸化接头蛋白14-3-3和Bcl-2家族的Bcl-2、Bim、Bid、Bad等成员而间接激活Bax。活化的Bax发生构象改变形成寡聚体并整合到线粒体外膜上，使之通透性增加，释放位于线粒体双层膜间的细胞色素C (Cytc)、细胞凋亡诱导因子(AIF)、Smac/DIABLO、核酸内切酶G (EndoG)等促凋亡的线粒体蛋白。在ATP/dATP存在的情况下，Cytc与凋亡蛋白酶活化因子(Apaf-1)形成多聚复合体，通过Apaf-1氨基端的Caspase募集结构域(CARD)募集胞质中的Caspase-9前体，经过其自身剪切活化并启动Caspase级联反应，激活下游的Caspase-3和Caspase-7，完成其相应底物的剪切，引起细胞凋。Smac/DIABLO可解除凋亡抑制蛋IAPs对Caspase的抑制，启动caspase依赖的线粒体途径的细胞凋亡。AIF和EndoG则能入核直接裂解DNA并引起染色质凝聚，通过非caspase依赖的线粒体途径介导细胞凋亡。</p><p>WANG等 [<xref ref-type="bibr" rid="hanspub.42297-ref16">16</xref>] 构建了大鼠短暂性全脑缺血再灌注模型，发现活化的JNK1/2会诱导Bad丝氨酸128位点发生磷酸化，导致与接头蛋白14-3-3的结合减弱，游离的Bad与线粒体膜上Bcl-Xl结合，使Bim等BH3-only蛋白得到释放，最后激活Bax而改变线粒体膜结构引起凋亡。CHO等 [<xref ref-type="bibr" rid="hanspub.42297-ref17">17</xref>] 构建了沙土鼠短暂性全脑缺血再灌注模型，运用TUNEL、Western blot、免疫组织化学染色和免疫荧光等技术检测沙土鼠的组织标本。结果显示伴随caspase-3、Bax表达增加，海马CA1区TUNEL阳性细胞比例增多，同时Bcl-2表达下降。ZHANG等 [<xref ref-type="bibr" rid="hanspub.42297-ref18">18</xref>] 用人脑血管平滑肌细胞(HBVSMC)构建了缺氧/复氧(H/R)模型，得到了相似的结果，从体外验证了H/R同样可以启动线粒体途径介导的细胞凋亡。</p></sec><sec id="s7_2"><title>3.2. 死亡受体通路</title><p>JNK通过转录依赖的方式介导死亡受体途径及线粒体途径的细胞凋亡。活化的JNK从细胞质转移入核，通过磷酸化激活c-Jun、c-Fos、Elk-1、ATF-2等转录因子而实现对凋亡相关基因的表达调控。活化的JNK入核后激活相关转录因子诱导肿瘤坏死因子(TNF)、FasL等死亡配体的表达而启动死亡受体通路的细胞凋亡：① TNF→肿瘤坏死因子受体(TNFR)→肿瘤坏死因子受体I型相关死亡结构域蛋白(TRADD)→含有死亡结构域的Fas相关蛋白(FADD)→caspase8→细胞凋亡，② FasL→Fas→死亡诱导信号复合物(DISC)→caspase8→caspase3→细胞凋亡；活性JNK入核后也能激活相关转录因子诱导Bim、Bid、DP5等BH3-only蛋白的表达，进一步激活Bax等促凋亡效应蛋白，从而启动线粒体通路的细胞凋亡。</p><p>Yu等 [<xref ref-type="bibr" rid="hanspub.42297-ref19">19</xref>] 发现大鼠局灶性脑缺血灌注会诱导GluR6-PSD95-MLK3信号传导模块的组装，促进JNK激活，从而上调FasL的转录表达，同时也促使Bax向线粒体移位，引起细胞色素C的释放和caspase-3的激活，最终引起海马CA1区的神经细胞凋亡。抑制FasL/Fas信号通路的基因表达可以减轻脑缺血再灌注带来的损伤 [<xref ref-type="bibr" rid="hanspub.42297-ref20">20</xref>]。GUAN等 [<xref ref-type="bibr" rid="hanspub.42297-ref21">21</xref>] 在大鼠全脑缺血再灌注损伤模型中发现海马CA1区DP5蛋白的表达水平提高，免疫共沉淀显示Bcl-2与DP5结合增强，而与Bax的结合减弱，推测激活的JNK通过促进DP5的表达，解除了Bcl-2对Bax的结合抑制, 使Bax转移至线粒体引起细胞凋亡。</p></sec><sec id="s7_3"><title>3.3. 内质网通路</title><p>近年越来越多研究表明，内质网应激(ERS)参与缺血性脑卒中的发生发展。内质网是真核细胞内合成及修饰蛋白质、脂类及糖类，贮存和释放钙离子的重要场所。正常情况下，内质网应激作为一种适应性保护反应可被诸多物理、化学及生物性刺激触发，并引起未折叠蛋白反应(UPR)，进一步激活蛋白激酶R样内质网激酶(PERK)、需肌醇激酶1 (IRE1)、活化转录因子6 (ATF6)三条信号通路，减少蛋白质的合成，加速未折叠蛋白的降解及正确折叠以减轻内质网压力，恢复内质网稳态，促进细胞存活 [<xref ref-type="bibr" rid="hanspub.42297-ref22">22</xref>]。但是脑缺血再灌注后，神经细胞内钙超载、兴奋性氨基酸细胞毒性作用、大量自由基生成及炎性反应等持久强烈的病理性因素诱发过度的ERS并进一步激活细胞的程序性死亡途径，引起细胞凋亡，加重缺血缺氧损伤。对此，ZHAO等 [<xref ref-type="bibr" rid="hanspub.42297-ref23">23</xref>] 研究证实ERS参与了脑缺血再灌注后JNK介导的神经元凋亡。</p><p>众多研究表明需肌醇酶1 (IRE1)-肿瘤坏死因子相关因子2 (TRAF2)-细胞凋亡信号调节激酶1 (ASK1)-JNK信号通路在内质网应激介导细胞凋亡中发挥重要作用，过强的内质网应激反应激活IRE1，活化的IRE1又募集TRAF2，然后与ASK1形成IRE1－TRAF2－ASK1复合物，激活JNK诱导细胞凋亡 [<xref ref-type="bibr" rid="hanspub.42297-ref24">24</xref>]。CHEN等 [<xref ref-type="bibr" rid="hanspub.42297-ref25">25</xref>] 采用双侧颈总动脉结扎法诱导大鼠CIRI，经过蛋白质组学分析，发现神经元的凋亡与 IRE1/TRAF2复合体的形成以及JNK1/2的持续激活密切相关。</p><p>葡萄糖调节蛋白(GRP78)是重要的内质网伴侣分子，对维持内质网稳态具有重要作用。正常情况下，GRP78与IRE1、ATF-6、PERK结合而处于无活性状态，发生ERS时，与三者解离转而结合未折叠蛋白，协助蛋白质的正确折叠。脑缺血早期UPR介导的GRP78表达增加，对神经细胞具有保护作用，诱导GRP78 的表达可以减轻神经元的凋亡 [<xref ref-type="bibr" rid="hanspub.42297-ref26">26</xref>]。长期过强的应激使内质网自稳功能失调，GRP78合成减少，细胞发生凋亡 [<xref ref-type="bibr" rid="hanspub.42297-ref27">27</xref>]。李建民等 [<xref ref-type="bibr" rid="hanspub.42297-ref28">28</xref>] 缺血再灌注早期GRP78与JNK表达趋势一致，后期出现GRP78表达持续下降，而JNK表达依然增高，应用SP600125抑制JNK活性后，GRP78表达增加。推测持久过强的ERS降低了GRP78的表达，释放出大量游离的IRE-1，促使IRE1-TRAF-2–ASK1复合体形成，激活JNK，介导细胞凋亡。</p></sec></sec><sec id="s8"><title>4. JNK抑制剂在脑缺血再灌注损伤中的作用</title><p>脑缺血再灌注时，JNK受到激活，使其抑制剂的筛选和应用成为了缺血性脑卒中防治研究的热点，在众多临床前动物实验中JNK抑制剂表现出良好的治疗潜能。</p><sec id="s8_1"><title>4.1. SP600125</title><p>SP600125是2001年发现的一种JNK特异性可逆的小分子抑制剂，不溶于水，可溶解于二甲基亚砜。通过与JNK1、JNK2、JNK3的ATP结合位点竞争性结合发挥抑制作用，对JNK的抑制要比对ERK1和p38强300多倍，可显著抑制c-Jun磷酸化，抑制肿瘤坏死因子α (TNF-α)、干扰素γ (IFN-γ)、环加氧酶2 (COX-2)和白介素2 (IL-2)等的表达。近年来被广泛应用于脑缺血再灌注损伤的研究。</p><p>GAO等 [<xref ref-type="bibr" rid="hanspub.42297-ref29">29</xref>] 采用小鼠局灶性脑缺血再灌注模型，探讨JNK活化在神经元凋亡中的作用，在缺血后的0.5~24小时JNK活性被诱导提高，进一步用免疫共沉淀法检测发现JNK的激活引起接头蛋白14-3-3磷酸化，促使Bax与14-3-3解离并移位到线粒体，介导线粒体途径的神经元凋亡。而通过尾静脉全身应用SP600125可降低p-JNK、Bim、DP5和Fas的表达，并抑制Bax的易位，减少细胞色素C和Smac从线粒体中释放以及下游caspase-9和caspase-3的激活，并呈剂量依赖性地缩小梗死体面积。GUAN等 [<xref ref-type="bibr" rid="hanspub.42297-ref30">30</xref>] 证实SP600125能抑制海马CA1区FasL的表达，同时抑制Bcl-2磷酸化和Bax从Bcl-2/Bax异二聚体释放。表明SP600125通过抑制死亡受体和线粒体两条途径促进神经元存活，而且缺血之前之后前后给药表现出相同的神经保护作用。MURATA等 [<xref ref-type="bibr" rid="hanspub.42297-ref31">31</xref>] 构建了大鼠短暂局灶性脑缺血再灌注模型，分别于再灌注后10分钟和7天后给予SP600125，发现了明显的疗效差异，早期治疗可以减少了梗死面积，延迟治疗则会产生恶化作用。</p></sec><sec id="s8_2"><title>4.2. AS601245</title><p>AS601245具有与SP600125相似的作用机制，不同的是前者对JNK3有更高的选择性。CARBONI等 [<xref ref-type="bibr" rid="hanspub.42297-ref32">32</xref>] 在沙土鼠短暂性全脑缺血再灌注模型和大鼠局短暂灶性缺血再灌注两种模型中，都证实了AS601245可以通过抑制JNK，减少c-Jun的表达和磷酸化，发挥对海马CA1区神经元的保护作用。后续研究 [<xref ref-type="bibr" rid="hanspub.42297-ref33">33</xref>] 采用沙土鼠短暂性全脑缺血再灌注模型，发现死亡受体途径于缺血再灌注后早期(2天)激活，而线粒体途径的激活出现在第5~7天，且两条途径皆被AS601245所抑制。当剂量为80 mg/kg时，AS601245可使神经轴突损伤减少67%，星形胶质细胞活化减少84%，说明AS601245不仅能减少全脑缺血后神经元损伤，同时也抑制星形胶质细胞增生，并改善脑缺血引起的长期记忆障碍 [<xref ref-type="bibr" rid="hanspub.42297-ref34">34</xref>]。转录因子FOXO3a与细胞凋亡、衰老、增殖、代谢、分化和肿瘤发生等密切相关，FOXO3a被Akt磷酸化时，FOXO3a与街头蛋白14-3-3结合定位于细胞质中。JNK的激活导致14-3-3丝氨酸184位点磷酸化，使FOXO3a/14-3-3复合体发生解离，FOXO3a转移入核，诱导促凋亡蛋白Bim等表达。最近LI等 [<xref ref-type="bibr" rid="hanspub.42297-ref35">35</xref>] 采用新生7日大鼠模拟新生儿缺氧缺血(HI)性脑损伤，发现JNK的激活伴随着细胞质中FOXO3a的去磷酸化，使后者核内移位增多，并引起促凋亡蛋白Bim和caspase-3的表达增加。JNK特异性抑制剂AS601245可提高FOXO3a的磷酸化水平，减少HI后FOXO3a的核内易位，使Bim和 caspase-3表达降低，最终表现为抑制神经元的凋亡和缩小脑梗死面积。</p></sec><sec id="s8_3"><title>4.3. IQ-1S</title><p>在脑缺血再灌注早期，神经型一氧化氮合酶(nNOS)来源的一氧化氮(NO)促进GluR6与MLK3发生S-亚硝化，增加了GluR6-PSD95-MLK3信号模块的组装，引起JNK激活 [<xref ref-type="bibr" rid="hanspub.42297-ref36">36</xref>]，同样ASK1也受到内源性NO的诱导发生S-亚硝基化 [<xref ref-type="bibr" rid="hanspub.42297-ref37">37</xref>]。外源性NO供体可抑制nNOS的激活，使再灌注早期S-亚硝化的GluR6、MLK3以及ASK1水平下降，对缺血性脑损伤起到保护作用。提示外源性NO供体可以通过调节MLK和ASK1活性减轻脑缺血再灌注的早期损伤。</p><p>PEI等 [<xref ref-type="bibr" rid="hanspub.42297-ref38">38</xref>] 在大鼠全脑缺血再灌注损伤模型中，发现nNOS催化合成的内源性NO可通过S-亚硝基化促进JNK3的激活，而外源性NO供体(硝普钠)可抑制JNK3的S-亚硝基化来逆转内源性NO的作用。最近SCHEPETKIN等 [<xref ref-type="bibr" rid="hanspub.42297-ref39">39</xref>] 筛选出了一种新型JNK特异性抑制剂IQ-1S，对JNK3具有较高的选择性。ATOCHIN等 [<xref ref-type="bibr" rid="hanspub.42297-ref40">40</xref>] 采用小鼠局灶性缺血再灌注模型，发现IQ-1S不仅是JNK抑制剂，还可作为外源性NO的供体，降低脑神经功能评分、减少脑梗死面积发挥脑保护作用。PLOTNIKOV等 [<xref ref-type="bibr" rid="hanspub.42297-ref41">41</xref>] 最新一项关于IQ-1S对大鼠全脑缺血再灌注损伤保护作用的研究发现，IQ-1S的神经保护特性可能是通过改善大脑微循环来介导的，表现为血管舒张增强，血液粘度降低，内皮功能障碍减轻，脑组织脂质过氧化受到抑制。</p></sec></sec><sec id="s9"><title>5. 结语</title><p>JNK作为参与CIRI的重要分子靶点，在过去十几年中其相关研究取得了长足的进步，多种JNK抑制剂的脑保护作用在细胞和动物模型中得到验证，然而JNK介导的生理功能的多样性以及与其他信号通路的间的串扰限制了各种抑制剂的全身应用。选择性干扰单个JNK亚型(比如大脑中表达的JNK3)或靶向JNK依赖性特定分子的结构域，增强抑制剂的特异性与针对性，可能是未来药物开发的主要方向，同时可为临床上CIRI的预防和治疗提供新的思路。</p></sec><sec id="s10"><title>基金项目</title><p>青岛市民生科技计划项目(19-6-1-50-nsh)。</p></sec><sec id="s11"><title>文章引用</title><p>王海鹏,于 群,王明山. JNK在脑缺血再灌注损伤细胞凋亡中的作用The Role of JNK in Apoptosis after Cerebral Ischemia-Reperfusion Injury[J]. 临床医学进展, 2021, 11(05): 21111-2119. https://doi.org/10.12677/ACM.2021.115302</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.42297-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Feigin, V.L., Krishnamurthi, R.V., Parmar, P., Norrving, B., Mensah, G.A., Bennett, D.A., et al. (2015) Update On the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology, 45, 161-176. &lt;br&gt;https://doi.org/10.1159/000441085</mixed-citation></ref><ref id="hanspub.42297-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Liu, L., Wang, D., Lawrence Wong, K.S. and Wang, Y. (2011) Stroke and Stroke Care in China: Huge Burden, Significant Workload, and a National Priority. Stroke, 42, 3651-3654. &lt;br&gt;https://doi.org/10.1161/STROKEAHA.111.635755</mixed-citation></ref><ref id="hanspub.42297-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Wang, W., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China: Results From a Nationwide Population-Based Survey of 480687 Adults. Circulation, 135, 759-771.  
&lt;br&gt;https://doi.org/10.1161/CIRCULATIONAHA.116.025250</mixed-citation></ref><ref id="hanspub.42297-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wang, D., Liu, J., Liu, M., Lu, C., Brainin, M. and Zhang, J. (2017) Patterns of Stroke between University Hospitals and Nonuniversity Hospitals in Mainland China: Prospective Multicenter Hospital-Based Registry Study. World Neurosurgery, 98, 258-265. &lt;br&gt;https://doi.org/10.1016/j.wneu.2016.11.006</mixed-citation></ref><ref id="hanspub.42297-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Eltzschig, H.K. and Eckle, T. (2011) Ischemia and Reperfusion—From Mechanism to Translation. Nature Medicine, 17, 1391-1401. &lt;br&gt;https://doi.org/10.1038/nm.2507</mixed-citation></ref><ref id="hanspub.42297-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">王道合, 拜承萍, 赵秀丽. 脑缺血再灌注损伤的防治方法与机制研究进展[J]. 中国实用神经疾病杂志, 2019, 22(17): 1958-1965.</mixed-citation></ref><ref id="hanspub.42297-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Coffey, E.T. (2014) Nuclear and Cytosolic JNK Signalling in Neurons. Nature Reviews. Neuroscience, 15, 285-299.  
&lt;br&gt;https://doi.org/10.1038/nrn3729</mixed-citation></ref><ref id="hanspub.42297-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cargnello, M. and Roux, P.P. (2011) Activation and Function of the MAPKs and their Substrates, the MAPK-activated Protein Kinases. Microbiology and Molecular Biology Reviews, 75, 50-83. &lt;br&gt;https://doi.org/10.1128/MMBR.00031-10</mixed-citation></ref><ref id="hanspub.42297-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Haeusgen, W., Herdegen, T. and Waetzig, V. (2011) The Bottleneck of JNK Signaling: Molecular and Functional Characteristics of MKK4 and MKK7. European Journal of Cell Biology, 90, 536-544.  
&lt;br&gt;https://doi.org/10.1016/j.ejcb.2010.11.008</mixed-citation></ref><ref id="hanspub.42297-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Patterson, K.I., Brummer, T., O’Brien, P.M. and Daly, R.J. (2009) Dual-Specificity Phosphatases: Critical Regulators with Diverse Cellular Targets. The Biochemical Journal, 418, 475-489. &lt;br&gt;https://doi.org/10.1042/BJ20082234</mixed-citation></ref><ref id="hanspub.42297-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Engström, W., Ward, A. and Moorwood, K. (2010) The Role of Scaffold Proteins in JNK Signalling. Cell Proliferation, 43, 56-66. &lt;br&gt;https://doi.org/10.1111/j.1365-2184.2009.00654.x</mixed-citation></ref><ref id="hanspub.42297-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sabapathy, K. (2012) Role of the JNK Pathway in Human Diseases. Progress in Molecular Biology and Translational Science, 106, 145-169. &lt;br&gt;https://doi.org/10.1016/B978-0-12-396456-4.00013-4</mixed-citation></ref><ref id="hanspub.42297-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ma, S., Liu, X., Cheng, B., Jia, Z., Hua, H. and Xin, Y. (2019) Chemical Characterization of Polysaccharides Isolated From Scrophularia Ningpoensis and its Protective Effect on the Cerebral Ischemia/Reperfusin Injury in Rat Model. International Journal of Biological Macromolecules, 139, 955-966. &lt;br&gt;https://doi.org/10.1016/j.ijbiomac.2019.08.040</mixed-citation></ref><ref id="hanspub.42297-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, Q.J., Xu, Y., Du, C.P. and Hou, X.-Y. (2012) SUMOylation of the Kainate Receptor Subunit GluK2 Contributes to the Activation of the MLK3-JNK3 Pathway Following Kainate Stimulation. FEBS Letters, 586, 1259-1264.  
&lt;br&gt;https://doi.org/10.1016/j.febslet.2012.03.048</mixed-citation></ref><ref id="hanspub.42297-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Zhen, Y., Ding, C., Sun, J., Wang, Y., Li, S. and Dong, L. (2016) Activation of the Calcium-Sensing Receptor Promotes Apoptosis by Modulating the JNK/p38 MAPK Pathway in Focal Cerebral Ischemia-Reperfusion in Mice. American Journal of Translational Research, 8, 911-921.</mixed-citation></ref><ref id="hanspub.42297-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X.T., Pei, D.S., Xu, J., Guan, Q.-H., Sun, Y.-F., Liu, X.-M., et al. (2007) Opposing Effects of Bad Phosphorylation at Two Distinct Sites by Akt1 and JNK1/2 on Ischemic Brain Injury. Cellular Signaling, 19, 1844-1856.  
&lt;br&gt;https://doi.org/10.1016/j.cellsig.2007.04.005</mixed-citation></ref><ref id="hanspub.42297-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Cho, Y.S., Shin, M.S., Ko, I.G., Kim, S.‑E., Kim, C.‑J., Sung, Y.‑H., et al. (2015) Ulinastatin Inhibits Cerebral Ischemia-Induced Apoptosis in the Hippocampus of Gerbils. Molecular Medicine Reports, 12, 1796-1802.  
&lt;br&gt;https://doi.org/10.3892/mmr.2015.3612</mixed-citation></ref><ref id="hanspub.42297-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, J., Xia, Y., Xu, Z. and Deng, X. (2016) Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK. Oxidative Medicine and Cellular Longevity, 2016, Article ID: 1518738. &lt;br&gt;https://doi.org/10.1155/2016/1518738</mixed-citation></ref><ref id="hanspub.42297-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Yu, C.Z., Li, C., Pei, D.S., Zong, Y.-Y., Shi, Q., Wen, X.-R., et al. (2009) Neuroprotection against Transient Focal Cerebral Ischemia and Oxygen-Glucose Deprivation by Interference with GluR6-PSD95 Protein Interaction. Neurochemical Research, 34, 2008-2021. &lt;br&gt;https://doi.org/10.1007/s11064-009-9990-z</mixed-citation></ref><ref id="hanspub.42297-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Xiao, B., Bi, F.F., Hu, Y.Q., Tian, F.-F., Wu, Z.-G., Mujlli, H.M., et al. (2007) Edaravone Neuroprotection Effected by Suppressing the Gene Expression of the FAS Signal Pathway Following Transient Focal Ischemia in Rats. Neurotoxicity Research, 12, 155-162. &lt;br&gt;https://doi.org/10.1007/BF03033912</mixed-citation></ref><ref id="hanspub.42297-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Guan, Q.H., Pei, D.S., Xu, T.L. and Zhang, G.-Y. (2006) Brain Ischemia/Reperfusion-Induced Expression of DP5 and Its Interaction with Bcl-2, Thus Freeing Bax From Bcl-2/Bax Dimmers Are Mediated by c-Jun N-terminal Kinase (JNK) Pathway. Neuroscience Letters, 393, 226-230. &lt;br&gt;https://doi.org/10.1016/j.neulet.2005.09.075</mixed-citation></ref><ref id="hanspub.42297-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Almanza, A., Carlesso, A., Chintha, C., Creedican, S., Doultsinos, D., Leuzzi, B., et al. (2019) Endoplasmic Reticulum Stress Signalling—From Basic Mechanisms to Clinical Applications. The FEBS Journal, 286, 241-278.  
&lt;br&gt;https://doi.org/10.1111/febs.14608</mixed-citation></ref><ref id="hanspub.42297-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, Y.N., Li, J.M., Chen, C.X., Zhang, P. and Li, S.X. (2015) Hypertension-Mediated Enhancement of JNK Activation in Association with Endoplasmic Reticulum Stress in Rat Model Hippocampus with Cerebral Ischemia-Reperfusion. Genetics and Molecular Research, 14, 10980-10990. &lt;br&gt;https://doi.org/10.4238/2015.September.21.10</mixed-citation></ref><ref id="hanspub.42297-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Chen, H., Yang, H., Pan, L., Wang, W., Liu, X., Ren, X., et al. (2016) The Molecular Mechanisms of XBP-1 Gene Silencing On IRE1α-TRAF2-ASK1-JNK Pathways in Oral Squamous Cell Carcinoma Under Endoplasmic Reticulum Stress. Biomedicine &amp; Pharmacotherapy, 77, 108-113. &lt;br&gt;https://doi.org/10.1016/j.biopha.2015.12.010</mixed-citation></ref><ref id="hanspub.42297-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Chen, J.H., Kuo, H.C., Lee, K.F. and Tsai, T.-H. (2015) Global Proteomic Analysis of Brain Tissues in Transient Ischemia Brain Damage in Rats. International Journal of Molecular Sciences, 16, 11873-11891.  
&lt;br&gt;https://doi.org/10.3390/ijms160611873</mixed-citation></ref><ref id="hanspub.42297-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ye, Z., Wang, N., Xia, P., Wang, E., Liao, J. and Guo, Q. (2013) Parecoxib Suppresses CHOP and Foxo1 Nuclear Translocation, but Increases GRP78 Levels in a Rat Model of Focal Ischemia. Neurochemical Research, 38, 686-693.  
&lt;br&gt;https://doi.org/10.1007/s11064-012-0953-4</mixed-citation></ref><ref id="hanspub.42297-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Kaufman, R.J., Scheuner, D., Schröder, M., Shen, X., Lee, K., Liu, C.Y., et al. (2002) The Unfolded Protein Response in Nutrient Sensing and Differentiation. Nature Reviews. Molecular Cell Biology, 3, 411-421.  
&lt;br&gt;https://doi.org/10.1038/nrm829</mixed-citation></ref><ref id="hanspub.42297-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">李建民, 赵雅宁, 刘乐, 常学优, 陈长香, 李淑杏. 高血压大鼠全脑缺血再灌注后海马区c-Jun氨基末端激酶激活与GRP78表达的关系[J]. 医学研究生学报, 2014, 27(5): 473-477.</mixed-citation></ref><ref id="hanspub.42297-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Gao, Y., Signore, A.P., Yin, W., Cao, G., Yin, X.-M., Sun, F., et al. (2005) Neuroprotection against Focal Ischemic Brain Injury by Inhibition of c-Jun N-terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway. Journal of Cerebral Blood Flow and Metabolism, 25, 694-712. &lt;br&gt;https://doi.org/10.1038/sj.jcbfm.9600062</mixed-citation></ref><ref id="hanspub.42297-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Guan, Q.H., Pei, D.S., Zhang, Q.G., Hao, Z.-B., Xu, T.-L. and Zhang, G.-Y. (2005) The Neuroprotective Action of SP600125, a New Inhibitor of JNK, On Transient Brain Ischemia/Reperfusion-Induced Neuronal Death in Rat Hippocampal CA1 via Nuclear and Non-Nuclear Pathways. Brain Research, 1035, 51-59.  
&lt;br&gt;https://doi.org/10.1016/j.brainres.2004.11.050</mixed-citation></ref><ref id="hanspub.42297-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Murata, Y., Fujiwara, N., Seo, J.H., Yan, F., Liu, X., Terasaki, Y., et al. (2012) Delayed Inhibition of c-Jun N-terminal Kinase Worsens Outcomes after Focal Cerebral Ischemia. The Journal of Neuroscience, 32, 8112-8115.  
&lt;br&gt;https://doi.org/10.1523/JNEUROSCI.0219-12.2012</mixed-citation></ref><ref id="hanspub.42297-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Carboni, S., Hiver, A., Szyndralewiez, C., Gaillard, P., Gotteland, J.-P. and Vitte, P.-A. (2004) AS601245 (1,3-Benzo- thiazol-2-Yl (2-[[2-(3-Pyridinyl) Ethyl] Amino]-4 Pyrimidinyl) Acetonitrile): A c-Jun NH2-terminal Protein Kinase Inhibitor with Neuroprotective Properties. The Journal of Pharmacology and Experimental Therapeutics, 310, 25-32.  
&lt;br&gt;https://doi.org/10.1124/jpet.103.064246</mixed-citation></ref><ref id="hanspub.42297-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Carboni, S., Antonsson, B., Gaillard, P., Gotteland, J.-P., Gillon, J.-Y. and Vitte, P.-A. (2005) Control of Death Receptor and Mitochondrial-Dependent Apoptosis by c-Jun N-terminal Kinase in Hippocampal CA1 Neurones Following Global Transient Ischaemia. Journal of Neurochemistry, 92, 1054-1060.  
&lt;br&gt;https://doi.org/10.1111/j.1471-4159.2004.02925.x</mixed-citation></ref><ref id="hanspub.42297-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Carboni, S., Boschert, U., Gaillard, P., Gotteland, J.-P., Gillon, J.-Y. and Vitte, P.-A. (2008) AS601245, a c-Jun NH2- Terminal Kinase (JNK) Inhibitor, Reduces Axon/Dendrite Damage and Cognitive Deficits after Global Cerebral Ischaemia in Gerbils. British Journal of Pharmacology, 153, 157-163. &lt;br&gt;https://doi.org/10.1038/sj.bjp.0707574</mixed-citation></ref><ref id="hanspub.42297-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Li, D., Li, X., Wu, J., Li, J., Zhang, L., Xiong, T., et al. (2015) Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis after Hypoxic-Ischemic Brain Damage in Neonatal Rats. PLoS ONE, 10, e0132998.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0132998</mixed-citation></ref><ref id="hanspub.42297-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Hu, S.Q., Ye, J.S., Zong, Y.Y., Sun, C.-C., Liu, D.-H., Wu, Y.-P., et al. (2012) S-Nitrosylation of Mixed Lineage Kinase 3 Contributes to its Activation after Cerebral Ischemia. The Journal of Biological Chemistry, 287, 2364-2377.  
&lt;br&gt;https://doi.org/10.1074/jbc.M111.227124</mixed-citation></ref><ref id="hanspub.42297-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Liu, D.H., Yuan, F.G., Hu, S.Q., Diao, F., Wu, Y.-P., Zong, Y.-Y., et al. (2013) Endogenous Nitric Oxide Induces Activation of Apoptosis Signal-Regulating Kinase 1 via S-Nitrosylation in Rat Hippocampus during Cerebral Ischemia- Reperfusion. Neuroscience, 229, 36-48. &lt;br&gt;https://doi.org/10.1016/j.neuroscience.2012.10.055</mixed-citation></ref><ref id="hanspub.42297-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Pei, D.S., Song, Y.J., Yu, H.M., Hu, W.-W., Du, Y. and Zhang, G.-Y. (2008) Exogenous Nitric Oxide Negatively Regulates c-Jun N-terminal Kinase Activation via Inhibiting Endogenous NO-Induced S-Nitrosylation during Cerebral Ischemia and Reperfusion in Rat Hippocampus. Journal of Neurochemistry, 106, 1952-1963.  
&lt;br&gt;https://doi.org/10.1111/j.1471-4159.2008.05531.x</mixed-citation></ref><ref id="hanspub.42297-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Schepetkin, I.A., Kirpotina, L.N., Khlebnikov, A.I., Hanks, T.S., Kochetkova, I., Pascual, D.W., et al. (2012) Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors. Molecular Pharmacology, 81, 832-845. &lt;br&gt;https://doi.org/10.1124/mol.111.077446</mixed-citation></ref><ref id="hanspub.42297-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Atochin, D.N., Schepetkin, I.A., Khlebnikov, A.I., Seledtsov, V.I., Swanson, H., Quinn, M.T., et al. (2016) A Novel Dual NO-Donating Oxime and c-Jun N-terminal Kinase Inhibitor Protects Against Cerebral Ischemia-Reperfusion Injury in Mice. Neuroscience Letters, 618, 45-49. &lt;br&gt;https://doi.org/10.1016/j.neulet.2016.02.033</mixed-citation></ref><ref id="hanspub.42297-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Plotnikov, M.B., Chernysheva, G.A., Aliev, O.I., Smol’iakova, V.I., Fomina, T.I., Osipenko, A.N., et al. (2019) Protective Effects of a New C-Jun N-Terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats. Molecules, 24, Article No. 1722. &lt;br&gt;https://doi.org/10.3390/molecules24091722</mixed-citation></ref></ref-list></back></article>